Fundraising FoxTriana Bio
Lexington, US · 10 known investors
Find your way into Triana Bio
Sign up to see every warm intro you have to Triana Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Triana Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
TRIANA Biomedicines is a venture-backed biopharmaceutical company developing small-molecule "molecular glue" therapeutics that induce protein:protein interactions to degrade or alter disease-causing target proteins, with an initial focus on targeted protein degradation for cancer. The company applies a target-first molecular glue discovery platform to pursue disease targets previously considered undruggable.
Founders & leadership
Investors · 10
How we know: the company's own site · Ascenta Capital's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Atlas Venture's portfolio page · the company's own site · a partner's Signal profile · board seat on SEC Form D · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: the company's own site · Lightspeed Venture Partners's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: RA Capital's portfolio page · the company's own site · Not right? Tell us
How we know: the company's own site · a partner's Signal profile · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Finchley Healthcare Ventures's portfolio page · Not right? Tell us
How we know: Pfizer Venture Investments's portfolio page · the VCSheet dataset · Not right? Tell us
Funding
SEC filings, press & company announcements$120M disclosed across 1 round · 2025
- $120MSeries BDec 2025 · 3 sourcesSource ↗
Source: company announcements and press reports — follow each round's link for the claim.
Founder mafia
2 people who came through Triana Bio went on to found or lead other companies.
Frequently asked questions
- What does Triana Bio do?
- TRIANA Biomedicines is a venture-backed biopharmaceutical company developing small-molecule "molecular glue" therapeutics that induce protein:protein interactions to degrade or alter disease-causing target proteins, with an initial focus on targeted protein degradation for cancer. The company applies a target-first molecular glue discovery platform to pursue disease targets previously considered undruggable.
- Who founded Triana Bio?
- Triana Bio was founded by Patrick Trojer.
- Who are Triana Bio's investors?
- Triana Bio's investors include Ascenta Capital, Atlas Venture, Lightspeed Venture Partners, RA Capital, Bessemer Venture Partners, Pfizer Ventures, Finchley Healthcare Ventures, Pfizer Venture Investments and 2 more.
- How much funding has Triana Bio raised?
- Triana Bio has disclosed $120M raised across 1 round.
- Where is Triana Bio headquartered?
- Triana Bio is headquartered in Lexington, US.